18th Annual Oxford Global Drug Discovery Summit 2017 Berlin

  • Conference Call
  • Oxford Global Con­fer­ences are proud to present the 18th Annual Drug Dis­cov­ery Lead­ers Sum­mit, which will take place on the 1112 June 2017 at the Hotel Palace in Berlin, Ger­many. The event is co-​located with our 5th Annual Dis­cov­ery Chem­istry and Drug Design Con­gress and our inau­gural Micro­biome Dis­cov­ery and Devel­op­ment Con­gress.

    Con­fer­ence Topics

    This sum­mit brings together the key opin­ion lead­ers and senior indus­try experts in drug dis­cov­ery, to dis­cuss the lat­est inno­v­a­tive dis­cov­ery strate­gies in dif­fer­ent ther­a­peu­tic areas as well as the most effec­tive enabling tech­nolo­gies and solutions.

    This year, we bring to you a fresh approach in our pro­gramme, focus­ing on the lat­est trends, updates and modal­i­ties in small and large mol­e­cule drug dis­cov­ery. There are two designed streams organ­ised around key pre­sen­ta­tions in val­i­dat­ing novel drug tar­gets and improv­ing lead opti­mi­sa­tion in dif­fer­ent ther­a­peu­tic areas; includ­ing Immuno-​Therapy, Autoim­mune, Oncol­ogy, Inflam­ma­tory, Car­dio­vas­cu­lar and Meta­bolic Dis­eases. The other new streams will address the most inno­v­a­tive assay devel­op­ment and screen­ing par­a­digms. Approaches in screen­ing includ­ing Phe­no­typic screen­ing, target-​based as well as RNAi screen­ing meth­ods will be cov­ered. The pro­gramme also brings the top open inno­va­tion com­pa­nies together, and dis­cus­sions on how best to approach effec­tive part­ner­ships and col­lab­o­ra­tions will take place over the 2 days.

    Our co-​located 5th Dis­cov­ery Chem­istry & Drug Design Con­gress pro­vides an unprece­dented oppor­tu­nity to gain insights from key pre­sen­ters of the com­pu­ta­tional chem­istry, dis­cov­ery chem­istry and med­i­c­i­nal field. Fea­tur­ing two dis­cov­ery chem­istry and drug design streams, the con­gress pro­gramme con­sists of mod­ern med­i­c­i­nal chem­istry strate­gies, com­pu­ta­tional chem­istry, PRO­TAC, automa­tion, enabling tech­nolo­gies and data inte­gra­tion and analy­sis. The con­gress also focused on new and novel approaches to drug design includ­ing pep­tide dis­cov­ery and devel­op­ment, inhibitors dis­cov­ery strate­gies in med­i­c­i­nal chem­istry, tar­geted cova­lent inhibitors (TCIs), FEP in structure-​based dis­cov­ery, pep­tide dis­cov­ery and chem­i­cal biology.

    Do not miss out on attend­ing our strat­i­fied pro­gram ensur­ing valu­able net­work­ing and inter­ac­tive ses­sions. Ben­e­fit from attend­ing com­pli­men­tary pre-​event webi­nars, panel dis­cus­sions and round­table dis­cus­sions on Novel Dis­cov­ery Tools, Open Inno­va­tion, Arti­fi­cial Intel­li­gence, Phe­no­typic vs. target-​based drug dis­cov­ery, ADMET, Gene Edit­ing and PROTAC.

    Speaker Lineup

    • Markus Hae­ber­lein – Dis­cov­ery, Alk­er­mes, Inc
    • Lorenz Mayr – Bio­log­i­cal Reagents & Assay Devel­op­ment, Astra Zeneca
    • Nick Ter­rett – Euro­pean Chem­istry Lead, MSD Research GmbH
    • Chris­tine Rothe – Dis­cov­ery & Alliance Man­age­ment, Pieris
    • Alas­tair Law­son – Struc­tural Biol­ogy, UCB
    • Klaus Bæk Simon­sen – Lundbeck
    • Chris Gib­son – Recur­sion Pharmaceuticals
    • Jim Xu – MSD
    • Patrick Kleyn – Drug Tar­get Inno­va­tion, EMD Serono
    • Peter Juhasz – Mech­a­nisms and Path­ways, Biogen
    • Thomas Vorherr – Pep­tide Dis­cov­ery, Novar­tis Insti­tutes for Bio­Med­ical Research, GDC/​IDDT
    • Stephen J. Shut­tle­worth – Karus Ther­a­peu­tics, Ltd.
    • Ste­van Djuric – Dis­cov­ery Chem­istry & Tech­nolo­gies, Abbvie
    • Guido Koch – Strate­gies & Tech­nolo­gies in Syn­the­sis, Novartis
    • Guido Hanauer – Trans­la­tional Med­i­cine, Takeda Pharmaceuticals
    • Con­stance Höfer – Priaxon
    • Jan Span­holtz – Gly­costem Therapeutics
    • Stephane Demotz – Dorphan
    • Frank Osterkamp – Chem­istry & Ana­lyt­ics, 3B Phar­ma­ceu­ti­cals GmbH
    • Matthias Frech – Mol­e­c­u­lar Inter­ac­tions & Bio­physics, Merck Serono
    • Her­man van Vli­j­men – Com­pu­ta­tional Chem­istry, Dis­cov­ery Sci­ences EU, Janssen, Phar­ma­ceu­ti­cal Com­pa­nies of John­son & Johnson
    • Daniel Zwill­ing – CNS Dis­cov­ery, Cir­cuit Therapeutics
    • Brion W. Mur­ray – Pfizer Oncol­ogy Research Unit
    • Jonathan Mason – Hep­tares Ther­a­peu­tics, Lund­beck Research
    • Stephen Hearty – Autoim­mune Team, Immunocore
    • Jose Duca – Computer-​Aided Drug Dis­cov­ery, Novartis
    • Nico­las Fis­cher – Research, Novimmune
    • Niclas Nils­son – R&D Open Inno­va­tion, LEO Pharma
    • Wern­gard Czechtizky – Med­i­c­i­nal Chem­istry, Sanofi
    • Ingo Muegge – Boehringer Ingelheim
    • Rod Hub­bard – Vernalis
    • Andrew Payne – UCB
    • Chris­t­ian Fis­cher – Chem­istry, Merck
    • Thierry Dor­val, HCS, Biotech­nol­ogy Chemical-​Biology, Servier
    • Yolanda Chong – John­son & Johnson
    • Fran­cois Sautel – Insti­tut de Recher­ché Pierre Fabre
    • Garry Pairaudeau – Research Out­sourc­ing, Astra Zeneca
    • Guido Zaman – Nether­lands Trans­la­tional Research Center
    • Ton Rijn­ders – Euro­pean Screen­ing Cen­ter, Lygature
    • Fabio Gas­parri – Cell Assay Tech­nolo­gies, Ner­viano Med­ical Sciences
    • Paul Andrews – National Phe­no­typic Screen­ing Cen­tre (NPSC), School of Life Sci­ences, Uni­ver­sity of Dundee
    • Ste­fano Gustin­cich – Lab­o­ra­tory of Neu­roge­nomics, Scuola Inter­nazionale Supe­ri­ore di Studi Avanzati

    Agenda

    In keep­ing with Oxford Global’s highly suc­cess­ful life sci­ences series, an expert panel of speak­ers will present a full con­fer­ence pro­gramme cov­er­ing the top­ics out­lined below:

    Day 1 Stream 1: Drug Dis­cover Inno­va­tion and Strate­gies, Enabling Technologies

    • Inno­v­a­tive Tar­get Dis­cov­ery and Dis­cov­ery Mod­els in: Meta­bolic and Car­dio­vas­cu­lar Ther­a­peu­tics, Car­diometa­bolic Drug Tar­gets, Can­cer — Immunother­apy, Oncol­ogy and Neu­ro­log­i­cal Diseases
    • Strate­gies in Tar­get Val­i­da­tion and Lead Optimization
    • Man­ag­ing Trans­la­tional Informatics
    • Data Man­age­ment in Discovery
    • Novel Drug Tar­gets and Screen­ing Tools
    • Open Inno­va­tion and Drug Discovery
    • Man­ag­ing Com­plex Dis­cov­ery Portfolios
    • ADMET Drug Discovery

    Day 1 Stream 2: Suc­cess­ful Phe­no­typic Drug Dis­cov­ery: High Con­tent Screening

    • Tech­niques and Tools in High Con­tent Technologies
    • Phe­no­typic Screen­ing Applications
    • 3D Cell Based Screen­ing Methods
    • Using Model Organ­isms for Screen­ing Methods
    • Novel Approaches for Phe­no­typic Screening
    • Using Patient-​Derived Tumour Mod­els for Screening
    • Screen­ing in Oncol­ogy and CNS Ther­a­peu­tic Areas
    • High Con­tent Screen­ing & Data Management

    Day 2 Stream 1: Novel Drug Tar­get Dis­cov­ery for Immuno-​Therapy, Autoim­mune Dis­eases and Oncology

    • Dis­cov­ery of T-​Cell Can­cer Immuno-​Therapy
    • Novel Ther­a­pies for Can­cer and Emerg­ing Targets
    • Kinase Inhibitors: Can­cer Immunother­apy Dis­cov­ery, Autoim­mune and Inflam­ma­tory Dis­eases, CNS and Neu­rode­gen­er­a­tive Disorders
    • Can­cer metab­o­lism /​cancer metab­o­lism tar­gets – includ­ing anti-​cachexic strategies

    Day 2 Stream 2: RNAi Screen­ing, Can­cer Genomics and Gene Edit­ing for Drug Discovery

    • Appli­ca­tions for Invivo RNAi Screening
    • Novel Appli­ca­tions in RNAi Screening
    • High-​Throughput Imag­ing and Genomics
    • 3D Cell Culture-​Based Screen
    • siRNA Screen­ing for Drug Tar­get Identification
    • Gene Edit­ing for Drug Discovery

    Sub­mit a poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

    How to sub­mit your poster

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organisation
    • Mail­ing address, Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £250 will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size. To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please reg­is­ter soon!

    starting: ending: 13.06.2017 Location: , Category:

    Timeline

    Conference START 13.06.2017 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Budapester Straße 45 Category Organiser More Info Conference Website

    Further interesting Conferences

    discover MORE CONFERENCES